The social network of carbon monoxide in medicine

Trends in Molecular Medicine

Volumn 19, Issue 1, 2013, Pages 3-11

  Wegiel, Barbara ^a   Hanto, Douglas W ^a   Otterbein, Leo E ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

CO releasing molecule; Gasotransmitter; Heme oxygenase 1; Hemoprotein; Innate immunity; Ischemia reperfusion injury; Organ transplantation; Sepsis

Indexed keywords

BILIVERDIN; CARBON MONOXIDE; CREATININE; CYCLOOXYGENASE 2; GAMMA INTERFERON; HEME OXYGENASE 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; IRON; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR NRF2; TUMOR NECROSIS FACTOR ALPHA;

BACTERIAL CLEARANCE; CATALYSIS; CD4+ CD25+ T LYMPHOCYTE; CELL FUNCTION; CREATININE BLOOD LEVEL; CYTOKINE PRODUCTION; DENDRITIC CELL; GENETIC CONSERVATION; HUMAN; INNATE IMMUNITY; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LYMPHOCYTE PROLIFERATION; NONHUMAN; PLEIOTROPY; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REPERFUSION INJURY; REVIEW; SEPSIS; SOCIAL NETWORK; VASCULAR DISEASE;

CARBON MONOXIDE; HEME OXYGENASE-1; HUMANS; IMMUNITY, INNATE; REPERFUSION INJURY; SEPSIS;

BACTERIA (MICROORGANISMS);

EID: 84871713925     PISSN: 14714914     EISSN: 1471499X     Source Type: Journal    
DOI: 10.1016/j.molmed.2012.10.001     Document Type: Review

References (81)

1. Maines M.D. The heme oxygenase system: a regulator of second messenger gases. Annu. Rev. Pharmacol. Toxicol. 1997, 37:517-554.
2. Otterbein L.E., et al. Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol. 2003, 24:449-455.
3. Ryter S.W., et al. Carbon monoxide and bilirubin: potential therapies for pulmonary/vascular injury and disease. Am. J. Respir. Cell Mol. Biol. 2007, 36:175-182.
4. Poss K.D., Tonegawa S. Heme oxygenase 1 is required for mammalian iron reutilization. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:10919-10924.
5. Kapturczak M.H., et al. Heme oxygenase-1 modulates early inflammatory responses: evidence from the heme oxygenase-1-deficient mouse. Am. J. Pathol. 2004, 165:1045-1053.
6. Gozzelino R., et al. Mechanisms of cell protection by heme oxygenase-1. Annu. Rev. Pharmacol. Toxicol. 2010, 50:323-354.
7. Otterbein L.E., et al. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat. Med. 2000, 6:422-428.
8. Chora A.A., et al. Heme oxygenase-1 and carbon monoxide suppress autoimmune neuroinflammation. J. Clin. Invest. 2007, 117:438-447.
9. Pamplona A., et al. Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria. Nat. Med. 2007, 13:703-710.
10. Chung S.W., et al. Heme oxygenase-1-derived carbon monoxide enhances the host defense response to microbial sepsis in mice. J. Clin. Invest. 2008, 118:239-247.
11. Sarady-Andrews J.K., et al. Biliverdin administration protects against endotoxin-induced acute lung injury in rats. Am. J. Physiol. Lung Cell. Mol. Physiol. 2005, 289:L1131-L1137.
12. Wegiel B., et al. Cell surface biliverdin reductase mediates biliverdin-induced anti-inflammatory effects via phosphatidylinositol 3-kinase and Akt. J. Biol. Chem. 2009, 284:21369-21378.
13. Yachie A., et al. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J. Clin. Invest. 1999, 103:129-135.
14. Otterbein L.E., et al. Carbon monoxide increases macrophage bacterial clearance through Toll-like receptor (TLR) 4 expression. Cell. Mol. Biol. (Noisy-le-grand) 2005, 51:433-440.
15. Wegiel B., et al. Biliverdin inhibits Toll-like receptor-4 (TLR4) expression through nitric oxide-dependent nuclear translocation of biliverdin reductase. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:18849-18854.
16. Ahmad Z., et al. Human biliverdin reductase is a leucine zipper-like DNA-binding protein and functions in transcriptional activation of heme oxygenase-1 by oxidative stress. J. Biol. Chem. 2002, 277:9226-9232.
17. Zuckerbraun B.S., et al. Carbon monoxide protects against liver failure through nitric oxide-induced heme oxygenase 1. J. Exp. Med. 2003, 198:1707-1716.
18. Lee S.S., et al. Heme oxygenase-1, carbon monoxide, and bilirubin induce tolerance in recipients toward islet allografts by modulating T regulatory cells. FASEB J. 2007, 21:3450-3457.
19. D'Amico G., et al. Inhibition of cellular respiration by endogenously produced carbon monoxide. J. Cell Sci. 2006, 119:2291-2298.
20. Chen B., et al. Carbon monoxide rescues heme oxygenase-1-deficient mice from arterial thrombosis in allogeneic aortic transplantation. Am. J. Pathol. 2009, 175:422-429.
21. Sato K., et al. Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants. J. Immunol. 2001, 166:4185-4194.
22. Vreman H.J., et al. Concentration of carbon monoxide (CO) in postmortem human tissues: effect of environmental CO exposure. J. Forensic Sci. 2006, 51:1182-1190.
23. Vreman H.J., et al. Determination of carbon monoxide (CO) in rodent tissue: effect of heme administration and environmental CO exposure. Anal. Biochem. 2005, 341:280-289.
24. Goldbaum L.R., et al. Mechanism of the toxic action of carbon monoxide. Ann. Clin. Lab. Sci. 1976, 6:372-376.
25. Foresti R., et al. Vasoactive properties of CORM-3, a novel water-soluble carbon monoxide-releasing molecule. Br. Pharmacol. 2004, 142:453-460.
26. Vandegriff K.D., et al. CO-MP4, a polyethylene glycol-conjugated haemoglobin derivative and carbon monoxide carrier that reduces myocardial infarct size in rats. Br. J. Pharmacol. 2008, 154:1649-1661.
27. Motterlini R., et al. Therapeutic applications of carbon monoxide-releasing molecules. Expert Opin. Investig. Drugs 2005, 14:1305-1318.
28. Motterlini R., Otterbein L.E. The therapeutic potential of carbon monoxide. Nat. Rev. Drug Discov. 2010, 9:728-743.
29. Otterbein L.E., et al. Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury. Nat. Med. 2003, 9:183-190.
30. Wegiel B., et al. Nitric oxide-dependent bone marrow progenitor mobilization by carbon monoxide enhances endothelial repair after vascular injury. Circulation 2010, 121:537-548.
31. Desmard M., et al. Mitochondrial and cellular heme-dependent proteins as targets for the bioactive function of the heme oxygenase/carbon monoxide system. Antioxid. Redox Signal. 2007, 9:2139-2155.
32. Foresti R., Motterlini R. Interaction of carbon monoxide with transition metals: evolutionary insights into drug target discovery. Curr. Drug Targets 2010, 11:1595-1604.
33. Wilkinson W.J., Kemp P.J. Carbon monoxide: an emerging regulator of ion channels. J. Physiol. 2011, 589:3055-3062.
34. Durante W., et al. cAMP induces heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle. Am. J. Physiol. 1997, 273:H317-H323.
35. Thorup C., et al. Carbon monoxide induces vasodilation and nitric oxide release but suppresses endothelial NOS. Am. J. Physiol. 1999, 277:F882-F889.
36. Larsen R., et al. A central role for free heme in the pathogenesis of severe sepsis. Sci. Transl. Med. 2010, 2:51ra71.
37. Tzima S., et al. Myeloid heme oxygenase-1 regulates innate immunity and autoimmunity by modulating IFN-β production. J. Exp. Med. 2009, 206:1167-1179.
38. Kaliman P.A., et al. Heme oxygenase activity and some indices of antioxidant protection in rat liver and kidney in glycerol model of rhabdomyolysis. Bull. Exp. Biol. Med. 2003, 135:37-39.
39. Otterbein L., et al. Hemoglobin provides protection against lethal endotoxemia in rats: the role of heme oxygenase-1. Am. J. Respir. Cell Mol. Biol. 1995, 13:595-601.
40. Cepinskas G., et al. Carbon monoxide liberated from carbon monoxide-releasing molecule CORM-2 attenuates inflammation in the liver of septic mice. Am. J. Physiol. Gastrointest. Liver Physiol. 2008, 294:G184-G191.
41. Lancel S., et al. Carbon monoxide rescues mice from lethal sepsis by supporting mitochondrial energetic metabolism and activating mitochondrial biogenesis. J. Pharmacol. Exp. Ther. 2009, 329:641-648.
42. Lo Iacono L., et al. A carbon monoxide-releasing molecule (CORM-3) uncouples mitochondrial respiration and modulates the production of reactive oxygen species. Free Radic. Biol. Med. 2011, 50:1556-1564.
43. Suliman H.B., et al. The CO/HO system reverses inhibition of mitochondrial biogenesis and prevents murine doxorubicin cardiomyopathy. J. Clin. Invest. 2007, 117:3730-3741.
44. Chin B.Y., et al. Hypoxia-inducible factor 1α stabilization by carbon monoxide results in cytoprotective preconditioning. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:5109-5114.
45. Brune B., Ullrich V. Inhibition of platelet aggregation by carbon monoxide is mediated by activation of guanylate cyclase. Mol. Pharmacol. 1987, 32:497-504.
46. Braudeau C., et al. Induction of long-term cardiac allograft survival by heme oxygenase-1 gene transfer. Gene Ther. 2004, 11:701-710.
47. Chauveau C., et al. Gene transfer of heme oxygenase-1 and carbon monoxide delivery inhibit chronic rejection. Am. J. Transplant. 2002, 2:581-592.
48. Soares M.P., et al. Heme oxygenase-1, a protective gene that prevents the rejection of transplanted organs. Immunol. Rev. 2001, 184:275-285.
49. Soares M.P., et al. Expression of heme oxygenase-1 can determine cardiac xenograft survival. Nat. Med. 1998, 4:1073-1077.
50. Yamashita K., et al. Heme oxygenase-1 is essential for and promotes tolerance to transplanted organs. FASEB J. 2006, 20:776-778.
51. Bach F.H. Heme oxygenase-1 and transplantation tolerance. Hum. Immunol. 2006, 67:430-432.
52. Akamatsu Y., et al. Heme oxygenase-1-derived carbon monoxide protects hearts from transplant associated ischemia reperfusion injury. FASEB J. 2004, 18:771-772.
53. Hanto D.W., et al. Intraoperative administration of inhaled carbon monoxide reduces delayed graft function in kidney allografts in swine. Am. J. Transplant. 2010, 10:2421-2430.
54. Caumartin Y., et al. Carbon monoxide-releasing molecules protect against ischemia-reperfusion injury during kidney transplantation. Kidney Int. 2011, 79:1080-1089.
55. Zhou H., et al. Protection against lung graft injury from brain-dead donors with carbon monoxide, biliverdin, or both. J. Heart Lung Transplant. 2011, 30:460-466.
56. Sahara H., et al. Carbon monoxide reduces pulmonary ischemia-reperfusion injury in miniature swine. J. Thorac. Cardiovasc. Surg. 2010, 139:1594-1601.
57. Sandouka A., et al. Treatment with CO-RMs during cold storage improves renal function at reperfusion. Kidney Int. 2006, 69:239-247.
58. Nakao A., et al. Heart allograft protection with low-dose carbon monoxide inhalation: effects on inflammatory mediators and alloreactive T cell responses. Transplantation 2006, 81:220-230.
59. Ikeda A., et al. Liver graft exposure to carbon monoxide during cold storage protects sinusoidal endothelial cells and ameliorates reperfusion injury in rats. Liver Transpl. 2009, 15:1458-1468.
60. Pizarro M.D., et al. Protective effects of a carbon monoxide-releasing molecule (CORM-3) during hepatic cold preservation. Cryobiology 2009, 58:248-255.
61. Wei Y., et al. Carbon monoxide-releasing molecule-2 (CORM-2) attenuates acute hepatic ischemia reperfusion injury in rats. BMC Gastroenterol. 2010, 10:42.
62. Zhang X., et al. Small interfering RNA targeting heme oxygenase-1 enhances ischemia-reperfusion-induced lung apoptosis. J. Biol. Chem. 2004, 279:10677-10684.
63. Ryter S.W., Choi A.M. Therapeutic applications of carbon monoxide in lung disease. Curr. Opin. Pharmacol. 2006, 6:257-262.
64. + regulatory T cells is dependent on expression of heme oxygenase-1 in antigen-presenting cells. Am. J. Pathol. 2008, 173:154-160.
65. Chauveau C., et al. Heme oxygenase-1 expression inhibits dendritic cell maturation and proinflammatory function but conserves IL-10 expression. Blood 2005, 106:1694-1702.
66. Remy S., et al. Carbon monoxide inhibits TLR-induced dendritic cell immunogenicity. J. Immunol. 2009, 182:1877-1884.
67. Cheng C., et al. Dendritic cell function in transplantation arteriosclerosis is regulated by heme oxygenase 1. Circ. Res. 2010, 106:1656-1666.
68. + regulatory T cells. J. Immunol. 2005, 174:5181-5186.
69. Zelenay S., et al. Heme oxygenase-1 is not required for mouse regulatory T cell development and function. Int. Immunol. 2007, 19:11-18.
70. Pae H.O., et al. Carbon monoxide produced by heme oxygenase-1 suppresses T cell proliferation via inhibition of IL-2 production. J. Immunol. 2004, 172:4744-4751.
71. Song R., et al. Carbon monoxide promotes Fas/CD95-induced apoptosis in Jurkat cells. J. Biol. Chem. 2004, 279:44327-44334.
72. Yoshida J., et al. Ex vivo application of carbon monoxide in UW solution prevents transplant-induced renal ischemia/reperfusion injury in pigs. Am. J. Transplant. 2010, 10:763-772.
73. Mayr F.B., et al. Effects of carbon monoxide inhalation during experimental endotoxemia in humans. Am. J. Respir. Crit. Care Med. 2005, 171:354-360.
74. Bauer I., Pannen B.H. Bench-to-bedside review: carbon monoxide - from mitochondrial poisoning to therapeutic use. Crit. Care 2009, 13:220.
75. Bathoorn E., et al. Anti-inflammatory effects of inhaled carbon monoxide in patients with COPD: a pilot study. Eur. Respir. J. 2007, 30:1131-1137.
76. Sunamura M., et al. Heme oxygenase-1 accelerates tumor angiogenesis of human pancreatic cancer. Angiogenesis 2003, 6:15-24.
77. Fang J., et al. In vivo antitumor activity of pegylated zinc protoporphyrin: targeted inhibition of heme oxygenase in solid tumor. Cancer Res. 2003, 63:3567-3574.
78. Was H., et al. Overexpression of heme oxygenase-1 in murine melanoma: increased proliferation and viability of tumor cells, decreased survival of mice. Am. J. Pathol. 2006, 169:2181-2198.
79. Vincent S.R., Hope B.T. Neurons that say NO. Trends Neurosci. 1992, 15:108-113.
80. Tan B.H., et al. Hydrogen sulfide: a novel signaling molecule in the central nervous system. Neurochem. Int. 2010, 56:3-10.
81. Wang R. Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter?. FASEB J. 2002, 16:1792-1798.